Los Angeles Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $606K | Hold |
19,214
| – | – | ﹤0.01% | 802 |
|
|
2025
Q1 | $629K | Buy |
19,214
+31
| +0.2% | +$1.02K | ﹤0.01% | 696 |
|
|
2024
Q4 | $694K | Sell |
19,183
-850
| -4% | -$30.7K | ﹤0.01% | 728 |
|
|
2024
Q3 | $625K | Buy |
+20,033
| New | +$625K | ﹤0.01% | 800 |
|
|
2023
Q3 | – | Sell |
-24,105
| Closed | -$725K | – | 1234 |
|
|
2023
Q2 | $725K | Buy |
+24,105
| New | +$725K | ﹤0.01% | 737 |
|
|
2021
Q3 | – | Sell |
-22,690
| Closed | -$699K | – | 1588 |
|
|
2021
Q2 | $699K | Sell |
22,690
-14,820
| -40% | -$457K | ﹤0.01% | 1017 |
|
|
2021
Q1 | $982K | Buy |
37,510
+16,630
| +80% | +$435K | ﹤0.01% | 903 |
|
|
2020
Q4 | $525K | Buy |
+20,880
| New | +$525K | ﹤0.01% | 1187 |
|
|
2020
Q3 | – | Sell |
-10,956
| Closed | -$260K | – | 1519 |
|
|
2020
Q2 | $260K | Buy |
10,956
+635
| +6% | +$15.1K | ﹤0.01% | 1331 |
|
|
2020
Q1 | $186K | Sell |
10,321
-6,255
| -38% | -$113K | ﹤0.01% | 1194 |
|
|
2019
Q4 | $393K | Hold |
16,576
| – | – | ﹤0.01% | 1071 |
|
|
2019
Q3 | $456K | Hold |
16,576
| – | – | ﹤0.01% | 1013 |
|
|
2019
Q2 | $548K | Buy |
+16,576
| New | +$548K | ﹤0.01% | 1014 |
|
|
2018
Q4 | – | Sell |
-21,091
| Closed | -$1.06M | – | 1376 |
|
|
2018
Q3 | $1.06M | Buy |
21,091
+380
| +2% | +$19.1K | 0.01% | 848 |
|
|
2018
Q2 | $1.24M | Sell |
20,711
-6,280
| -23% | -$376K | 0.01% | 833 |
|
|
2018
Q1 | $1.24M | Buy |
26,991
+125
| +0.5% | +$5.72K | 0.01% | 767 |
|
|
2017
Q4 | $1.07M | Buy |
26,866
+13,805
| +106% | +$550K | 0.01% | 841 |
|
|
2017
Q3 | $522K | Buy |
+13,061
| New | +$522K | ﹤0.01% | 1002 |
|